These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19922107)

  • 1. Clinical significance of measuring levels of tumor necrosis factor-alpha and soluble interleukin-2 receptor in nasopharyngeal carcinoma.
    Hsiao SH; Lee MS; Lin HY; Su YC; Ho HC; Hwang JH; Lee CC; Hung SK
    Acta Otolaryngol; 2009 Dec; 129(12):1519-23. PubMed ID: 19922107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble TNF and IL-2 receptors in patients with breast cancer.
    Tesarová P; Kvasnicka J; Umlaufová A; Homolková H; Jirsa M; Tesar V
    Med Sci Monit; 2000; 6(4):661-7. PubMed ID: 11208388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines (IL-6, TNF-alpha, IL-1alpha) and soluble interleukin-2 receptor as serum tumor markers in multiple myeloma.
    Filella X; Blade J; Guillermo AL; Molina R; Rozman C; Ballesta AM
    Cancer Detect Prev; 1996; 20(1):52-6. PubMed ID: 8907203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
    Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Soluble TNF and IL-2 receptors in patients with breast carcinoma].
    Tesarová P; Kvasnicka J; Umlaufová A; Homolková J; Jirsa M; Tesar V
    Cas Lek Cesk; 1998 May; 137(11):341-5. PubMed ID: 9727208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum soluble interleukin-2 receptor levels in patients with renal cell carcinoma: a comparison of values before and after surgery].
    Tsukamoto S; Ishikawa S; Yamauchi A; Saitou S
    Hinyokika Kiyo; 2000 Oct; 46(10):695-9. PubMed ID: 11215193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Seric soluble interleukin-2 receptor alpha in nasopharyngeal carcinoma in Tunisia. Prospective study about 45 cases].
    Jmal A; Ghanem A; Boussen H; Gara Y; Abaza H; Gara S; Harzallah L; Ladgham A; Guemira F
    Tunis Med; 2007 Aug; 85(8):651-4. PubMed ID: 18254285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of tumor necrosis factor and soluble interleukin 2 receptor as markers of disease activity and prognosis in childhood leukemia and lymphoma.
    Kalmanti M; Karamolengou K; Dimitriou H; Tosca A; Vlachonikolis I; Peraki M; Georgoulias V; Kalmantis T
    Int J Hematol; 1993 Apr; 57(2):147-52. PubMed ID: 8494993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous tumor necrosis factor-alpha in patients with nasopharyngeal carcinoma.
    Yadav M
    Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):123-6. PubMed ID: 1948253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma].
    Shimomura Y; Tsurumi H; Sawada M; Yamada T; Hara T; Fukuno K; Goto H; Moriwaki H
    Rinsho Ketsueki; 1999 Aug; 40(8):639-45. PubMed ID: 10496038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The level of soluble interleukin 2 receptor in esophageal carcinoma patients before and after radiotherapy].
    Liu X; An H; Jiang Y
    Zhonghua Zhong Liu Za Zhi; 1995 Mar; 17(2):97-9. PubMed ID: 7656815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma.
    Boyano MD; Garcia-Vázquez MD; López-Michelena T; Gardeazabal J; Bilbao J; Cañavate ML; Galdeano AG; Izu R; Díaz-Ramón L; Raton JA; Díaz-Pérez JL
    Br J Cancer; 2000 Oct; 83(7):847-52. PubMed ID: 10970683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal cell carcinoma-associated immune impairment that may interfere with the response to cytokine therapy.
    Lauerová L; Dusek L; Simícková M; Rovný F; Spurný V; Rovný A; Slampa P; Zaloudík J; Rejthar A; Wotke J; Kovarík J
    Neoplasma; 1999; 46(3):141-9. PubMed ID: 10613588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between serum levels of soluble interleukin-2 receptor and various disease parameters in patients with squamous cell carcinoma of the esophagus.
    Oka M; Hazama S; Takahashi M; Yamamoto K; Abe T; Yoshino S; Hayashi H; Tangoku A
    Hepatogastroenterology; 1999; 46(28):2254-9. PubMed ID: 10521976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-2-microglobulin (beta 2M) as a tumor marker in nasopharyngeal carcinoma.
    Lee JK; Tsai SC; Hsieh JF; Ho YJ; Sun SS; Kao CH
    Anticancer Res; 2000; 20(6C):4765-8. PubMed ID: 11205215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles of serum IL-18, IL-10, TNF-alpha and sIL-2R in patients with chronic hepatitis C.
    Jia HY; Du J; Zhu SH; Ma YJ; Chen HY; Yang BS; Cai HF
    Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):378-82. PubMed ID: 14607710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble interleukin-2 receptor as a clinical parameter for nasopharyngeal carcinoma.
    Hsu MM; Chen YJ; Chang YL; Ko JY; Sheen TS
    Asian Pac J Allergy Immunol; 1995 Jun; 13(1):1-4. PubMed ID: 7488337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [TNF-alpha and soluble interleukin-2 receptor and glomerular sclerosis in primary nephrotic syndrome in children].
    Pogan A; Sancewicz-Pach K; Miezyński W
    Wiad Lek; 2005; 58 Suppl 1():39-44. PubMed ID: 16060083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A study of cytokine expression in peripheral blood of patients with Graves' ophthalmopathy].
    Tang L; Luo Q; Zhou X; Xia R
    Zhonghua Yan Ke Za Zhi; 2002 Mar; 38(3):165-7. PubMed ID: 11955323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue polypeptide specific antigen (TPS) as a tumor marker in nasopharyngeal carcinoma.
    Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
    Anticancer Res; 2000; 20(6C):4661-3. PubMed ID: 11205197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.